Business Segments · Depreciation
Neuroscience — Depreciation
Medtronic Neuroscience — Depreciation decreased by 74.0% to $80M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 70.1%, from $268M to $80M.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2022
Last reportedQ4 2025Feb 24, 2026
Rolls up toD&A
How to read this metric
High depreciation relative to assets may indicate a need for future capital expenditure to replace aging equipment.
Detailed definition
This is the systematic allocation of the cost of tangible assets used by the Neuroscience segment over their useful live...
Peer comparison
Comparable to depreciation expense disclosures in segment-level reporting for capital-intensive industries.
Metric ID:
mdt_segment_neuroscience_depreciationHistorical Data
22 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q2 '24 | Q3 '24 | Q3 '24 | Q4 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q2 '25 | Q3 '25 | Q3 '25 | Q4 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $66.25M | $66.25M | $66.25M | $66.25M | $66.75M | $66.75M | $66.75M | $66.75M | $43M | $248M | $65M | $262M | $71M | $268M | $73M | $46M | $289M | $77M | $282M | $79M | $308M | $80M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.8% | +0.0% | +0.0% | +0.0% | -35.6% | +476.7% | -73.8% | +303.1% | -72.9% | +277.5% | -72.8% | -37.0% | +528.3% | -73.4% | +266.2% | -72.0% | +289.9% | -74.0% |
| YoY Change | — | — | — | — | +0.8% | +0.8% | +0.8% | +0.8% | -35.6% | +271.5% | -2.6% | +292.5% | +6.4% | +301.5% | +9.4% | +7.0% | +16.5% | -69.0% | +7.6% | -69.8% | +14.9% | -70.1% |
Range$43M – $308M
CAGR+3.7%
Avg YoY Growth+38.0%
Median YoY Growth+3.6%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Medtronic's neuroscience — depreciation?
- Medtronic (MDT) reported neuroscience — depreciation of $80M in Q4 2025.
- How has Medtronic's neuroscience — depreciation changed year-over-year?
- Medtronic's neuroscience — depreciation decreased by 70.1% year-over-year, from $268M to $80M.
- What does neuroscience — depreciation mean?
- The non-cash expense representing the aging of equipment used in the neuroscience business.